Nordic Pharma UK is an affiliate member of the Nordic Group of companies. This group operates marketing, sales, drug development, manufacturing, regulatory and clinical trial functions. The organisation started in Scandinavia in 1995 and has now become established across Europe.

Nordic Pharma is constantly considering a number of in-licensing opportunities on a local (United Kingdom and Republic of Ireland) or pan-European basis.

Nordic Pharma's prime focus is prescription medicines in the secondary care setting within the following target areas:

• Haematology
• Oncology
• Critical Care
• Specialist Injectables

Via: 

• Co-marketing
• In-licensing
• Acquisition

Nordic Pharma UK will expand infrastructure to fit the opportunity and will also therefore consider opportunities in other therapeutic areas.